Robo.ai Inc. (AIIO) Stock: Rises as September Revenue Tops $100 Million
TLDR Robo.ai stock rises 2.26% after September revenue climbs above $100 million. Robo.ai targets about $600 million in total reve...
GlobalFoundries Partners with Xanadu Quantum (XNDU) for Mass Production of Photo...
Xanadu Quantum (XNDU) stock surged 9% after securing a manufacturing partnership with GlobalFoundries to produce quantum photonic...
FDA Fast-Tracks HeartBeam’s (BEAT) At-Home Heart Attack Device in Under 30 Days
HeartBeam (BEAT) stock surged 62% after FDA granted Breakthrough Device status for its at-home heart attack detection system in ju...
Netlist, Inc. (NLST) Stock: Surge 13% as Micron Signs Five-Year $600M Patent Lic...
TLDR Netlist stock rises 13% after Micron agrees to a five-year $600M patent license. Micron will pay Netlist $30M quarterly from...
ARK Invest Acquires $6.1 Million Stake in Recursion Pharmaceuticals (RXRX) While...
Cathie Wood's ARK Invest sold $17.1M in Twist Bioscience and purchased Recursion Pharmaceuticals, Intellia Therapeutics, and Verac...
Delta Air Lines (DAL) Reports Q3 Results Oct. 9 as Fuel Costs Jump 40% Year-Over...
Delta Air Lines (DAL) reports Q3 earnings Oct. 9. UBS keeps Buy rating at $105 target as fuel costs surge 40% and estimates face d...
Xanadu (XNDU) Stock: Jumps 11% on GlobalFoundries Quantum Deal
TLDR XNDU stock jumps 11.28% after Xanadu unveils a GlobalFoundries partnership. GlobalFoundries will support Xanadu’s 300 mm phot...
Biodefense Shares Surge as Russian Lab Worker’s Death Sparks Health Concerns
Vaccine stocks including Novavax and Moderna rallied after a lab technician died following suspected plague exposure at a Russian...
Rezolve AI PLC (RZLV) Stock Surges as Court Approval Paves Way for $300M Repurch...
TLDR Rezolve AI wins court approval, advancing its planned $300M share repurchase. RZLV stock rises as court backing moves the cap...
JPMorgan Upgrades Corteva (CTVA) to Buy After Vylor Spinoff, Sets $19 Target
Corteva (CTVA) stock climbed 9% after JPMorgan upgraded shares to Buy with a $19 target following the company's October 1 separati...